Zahra Shafaghat

Zahra Shafaghat

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 April 2023 in Archives of Virology
Verified
Journal Article
Open access
PDF file
TNTahereh Nazary
Tahereh Nazary
AAAzin Aghamajidi
Azin Aghamajidi
MDMaryam Dorfaki
Maryam Dorfaki
FKFatemeh Keshavarz
Fatemeh Keshavarz
ZSZahra Shafaghat
Zahra Shafaghat
RJReza Jafari
Reza Jafari
B lymphocytes play a vital role in the human defense against viral infections by producing specific antibodies. They are also critical for the prevention of infectious diseases by vaccination, and their activation influences the efficacy of the vaccination. Since the beginning of coronavirus disease 2019 (COVID-19), which became the main concern of the world health system, many efforts have been made to treat and prevent the disease. However, for the development of successful therapeutics and vaccines, it is necessary to understand the interplay between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, and the immune system. The innate immune system provides primary and nonspecific defense against the virus, but within several days after infection, a virus-specific immune response is provided first by antibody-producing B cells, which are converted after the resolution of disease to memory B cells, which provide long-term immunity. Although a failure in B cell activation or B cell dysfunction can cause a severe form of the disease and also lead to vaccination inefficiency, some individuals with B cell immunodeficiency have shown less production of the cytokine IL-6, resulting in a better disease outcome. In this review, we present the latest findings on the interaction between SARS-CoV-2 and B lymphocytes during COVID-19 infection.

20 February 2024 in Iranian Journal of Allergy, Asthma and Immunology
Verified
Journal Article
Closed access
MSMarziyeh Soltani
Marziyeh Soltani
YMYousef Mirzaei
Yousef Mirzaei
AMAli Hussein Mer
Ali Hussein Mer
MMMina Mohammadrezaei
Mina Mohammadrezaei
ZSZahra Shafaghat
Zahra Shafaghat
NBNader Bagheri
Nader Bagheri
Chizophrenia is one of the most severely debilitating mental disorders that affects 1.1% of the world's population. The exact cause of the disease is not known, but genetics, environmental factors (such as infectious agents, season and region of birth, exposure to viruses, low birth weight, advanced paternal age, and tobacco), and immune system dysfunction can all contribute to the development of schizophrenia. Recently, the role of the immune system in schizophrenia has received much attention. Both acquired and innate immune systems are involved in the pathogenesis of schizophrenia and facilitate the disease's progression. Almost all cells of the immune system including microglia, B cells, and T cells play an important role in the blood-brain barrier damage, inflammation, and in the progression of this disease. In schizophrenia, the integrity of the blood-brain barrier is reduced and then the immune cells are recruited into the endothelium following an increase in the expression of cell adhesion molecules. The entry of immune cells and cytokines leads to inflammation and antibody production in the brain. Accordingly, the results of this study strengthen the hypothesis that the innate and acquired immune systems are involved in the pathogenesis of schizophrenia.

3 September 2025 in Journal of Nanoparticle Research
Verified
Journal Article
Closed access
PDF file
RFRahil Fallahi
Rahil Fallahi
ZSZahra Shafaghat
Zahra Shafaghat
SMSara Minaeian
Sara Minaeian
MGMohammad Taghi Goodarzi
Mohammad Taghi Goodarzi
MRMona Roozbehani
Mona Roozbehani
FFFatemeh Faraji
Fatemeh Faraji